Francisco Diaz-Mitoma is Chief Medical Officer at VBI Vaccines Inc/BC (VBIV). They have made 6 open-market trades across 1 company since 2017, most recently 2019-10-04.
CIK 0001701865
6 open-market purchases totalling $140K since 2017, never a sale. Across 6 scored buys the stock is up 13.5% at ninety days, and 10.3 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VBIV | 14,500 | $947 |
Shares reported on the most recent Form 4, priced at the 2019-10-07 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 67% | 50% |
| Avg Move | -3.9% | +1.3% | +13.5% |
| Alpha | -5.0% | -0.9% | +10.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VBIV | BUY | 2019-09-30 | 2019-10-07 | $0.50 | $27K | -2.8% | +1.9% | +155.1% |
| VBIV | BUY | 2019-06-27 | 2019-07-01 | $1.07 | $9K | -19.9% | -30.9% | -55.5% |
| VBIV | BUY | 2019-06-20 | 2019-06-20 | $0.87 | $45K | +2.1% | -13.8% | -29.2% |
| VBIV | BUY | 2018-08-02 | 2018-08-06 | $2.13 | $19K | -1.0% | +11.3% | +14.9% |
| VBIV | BUY | 2018-05-11 | 2018-05-14 | $3.05 | $30K | -7.4% | +19.2% | -43.7% |
| VBIV | BUY | 2017-08-21 | 2017-08-22 | $3.17 | $10K | +5.9% | +20.1% | +39.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.